Stay updated on Distribution of BI 754111 in Cancer Patients Clinical Trial
Sign up to get notified when there's something new on the Distribution of BI 754111 in Cancer Patients Clinical Trial page.

Latest updates to the Distribution of BI 754111 in Cancer Patients Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedAdded Results Submission Events (1) and Revision: v3.3.3. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page history.SummaryDifference0.3%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe Record History shows a new version where the status changes from 'No Results Posted' to 'Results Submitted'. This indicates that results for the study have been submitted.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page history shows an addition of Revision: v3.3.2 and a removal of Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedRemoved the site-wide notice about government funding and NIH operating status that previously appeared on the page. This change does not affect core trial content, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check57 days agoChange DetectedUpdates to the Study Status and Recruitment Status sections, including revised locations and contact details. The changes reflect the current state of the trial and who can participate.SummaryDifference0.1%

- Check86 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that NI H Clinical Center is open and where to check status.SummaryDifference10%

Stay in the know with updates to Distribution of BI 754111 in Cancer Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Distribution of BI 754111 in Cancer Patients Clinical Trial page.